BIOLOGICS, INC.
Doing business as BIOLOGICS BY MCKESSON
- CARY, NC 27513-2292
- biologics.mckesson.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $541.9K
- Awards on record
- 18
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
BIOLOGICS, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About BIOLOGICS, INC.
- Headquarters
- CARY, NC 27513-2292
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIGVRYEDLFU6J3
- CAGE6LEB9
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $541.9K
- Awards on record
- 18
- Top funding agencies
- Federal Prison System / Bureau of Prisons · Department of Veterans Affairs
Awards
15B10626P00000273
Completed: Period of performance ended Sep 30, 2026SPECIALTY MEDICATION DOS: 4/3- 9/30/2026
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $121.4K
- Period of performance
- Apr 3, 2026 – Sep 30, 2026
36C26126P0068
Completed: Period of performance ended Dec 14, 2025LENALIDOMIDE 15MG, 10MG NDCS: 76282-0699-47, 76282-0698-48
Department of Veterans Affairs
- Obligated
- $29.6K
- Period of performance
- Oct 14, 2025 – Dec 14, 2025
36C26125P1616
Completed: Period of performance ended Nov 23, 2025LENALIDOMIDE 5MG NDC: 76282-0697-48
Department of Veterans Affairs
- Obligated
- $18.7K
- Period of performance
- Sep 23, 2025 – Nov 23, 2025
36C26125P1544
Completed: Period of performance ended Nov 9, 2025LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $77.5K
- Period of performance
- Sep 9, 2025 – Nov 9, 2025
36C25925P1069
Completed: Period of performance ended Sep 30, 2025EMERGENCY! PHARMACY BUY, LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $10K
- Period of performance
- Aug 21, 2025 – Sep 30, 2025
15B50525P00000138
Completed: Period of performance ended Sep 12, 2025CANCER DRUG BIOLOGICS (MCKESSON) SEPT ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Sep 12, 2025 – Sep 12, 2025
15B50525P00000140
Completed: Period of performance ended Aug 31, 2025CANCER DRUG BIOLOGICS (MCKESSON) AUGUST ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Aug 31, 2025 – Aug 31, 2025
15B50525P00000139
Completed: Period of performance ended Jul 31, 2025CANCER DRUG BIOLOGICS (MCKESSON) JULY ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Jul 31, 2025 – Jul 31, 2025
15B50525P00000113
Completed: Period of performance ended Jun 25, 2025CANCER DRUG BIOLOGICS (MCKESSON) JUNE ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Jun 25, 2025 – Jun 25, 2025
15B50525P00000089
Completed: Period of performance ended May 31, 2025CANCER DRUG BIOLOGICS (MCKESSON) MAY ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- May 1, 2025 – May 31, 2025
15B50525P00000082
Completed: Period of performance ended May 7, 2025CANCER DRUG BIOLOGICS (MCKESSON) APR ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- May 7, 2025 – May 7, 2025
15B50525P00000067
Completed: Period of performance ended Mar 31, 2025CANCER DRUG BIOLOGICS (MCKESSON) MAR ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Mar 31, 2025 – Mar 31, 2025
15B50525P00000063
Completed: Period of performance ended Feb 18, 2025TURALIO 125MG CANCER DRUG BIOLOGICS (BY MCKESSON) FEB 2025 ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Jan 1, 2025 – Feb 18, 2025
15B50525P00000027
Completed: Period of performance ended Jan 31, 2025TURALIO 125MG CANCER DRUG BIOLOGICS (BY MCKESSON) DEC ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $22.1K
- Period of performance
- Dec 1, 2024 – Jan 31, 2025
15B50525P00000037
Completed: Period of performance ended Jan 10, 2025CANCER DRUG BIOLOGICS (MCKESSON) DEC ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $21.5K
- Period of performance
- Jan 10, 2025 – Jan 10, 2025
15B50525P00000024
Completed: Period of performance ended Nov 30, 2024CANCER DRUG BIOLOGICS (MCKESSON) NOV ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $21.5K
- Period of performance
- Nov 1, 2024 – Nov 30, 2024
15B50525P00000012
Completed: Period of performance ended Oct 31, 2024CANCER DRUG BIOLOGICS (MCKESSON) OCT ORDER FY25
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $21.5K
- Period of performance
- Oct 1, 2024 – Oct 31, 2024
15B50524P00000105
Completed: Period of performance ended Sep 30, 2024CANCER DRUG FOR NEW INMATE (SEPTEMBER ORDER)
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $21.5K
- Period of performance
- Sep 17, 2024 – Sep 30, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
15B10626P00000273 SPECIALTY MEDICATION DOS: 4/3- 9/30/2026 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $121.4K | Apr 3, 2026 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26126P0068 LENALIDOMIDE 15MG, 10MG NDCS: 76282-0699-47, 76282-0698-48 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $29.6K | Oct 14, 2025 – Dec 14, 2025 | Completed: Period of performance ended Dec 14, 2025 |
36C26125P1616 LENALIDOMIDE 5MG NDC: 76282-0697-48 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $18.7K | Sep 23, 2025 – Nov 23, 2025 | Completed: Period of performance ended Nov 23, 2025 |
36C26125P1544 LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $77.5K | Sep 9, 2025 – Nov 9, 2025 | Completed: Period of performance ended Nov 9, 2025 |
36C25925P1069 EMERGENCY! PHARMACY BUY, LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10K | Aug 21, 2025 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
15B50525P00000138 CANCER DRUG BIOLOGICS (MCKESSON) SEPT ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Sep 12, 2025 – Sep 12, 2025 | Completed: Period of performance ended Sep 12, 2025 |
15B50525P00000140 CANCER DRUG BIOLOGICS (MCKESSON) AUGUST ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Aug 31, 2025 – Aug 31, 2025 | Completed: Period of performance ended Aug 31, 2025 |
15B50525P00000139 CANCER DRUG BIOLOGICS (MCKESSON) JULY ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Jul 31, 2025 – Jul 31, 2025 | Completed: Period of performance ended Jul 31, 2025 |
15B50525P00000113 CANCER DRUG BIOLOGICS (MCKESSON) JUNE ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Jun 25, 2025 – Jun 25, 2025 | Completed: Period of performance ended Jun 25, 2025 |
15B50525P00000089 CANCER DRUG BIOLOGICS (MCKESSON) MAY ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | May 1, 2025 – May 31, 2025 | Completed: Period of performance ended May 31, 2025 |
15B50525P00000082 CANCER DRUG BIOLOGICS (MCKESSON) APR ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | May 7, 2025 – May 7, 2025 | Completed: Period of performance ended May 7, 2025 |
15B50525P00000067 CANCER DRUG BIOLOGICS (MCKESSON) MAR ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Mar 31, 2025 – Mar 31, 2025 | Completed: Period of performance ended Mar 31, 2025 |
15B50525P00000063 TURALIO 125MG CANCER DRUG BIOLOGICS (BY MCKESSON) FEB 2025 ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Jan 1, 2025 – Feb 18, 2025 | Completed: Period of performance ended Feb 18, 2025 |
15B50525P00000027 TURALIO 125MG CANCER DRUG BIOLOGICS (BY MCKESSON) DEC ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $22.1K | Dec 1, 2024 – Jan 31, 2025 | Completed: Period of performance ended Jan 31, 2025 |
15B50525P00000037 CANCER DRUG BIOLOGICS (MCKESSON) DEC ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $21.5K | Jan 10, 2025 – Jan 10, 2025 | Completed: Period of performance ended Jan 10, 2025 |
15B50525P00000024 CANCER DRUG BIOLOGICS (MCKESSON) NOV ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $21.5K | Nov 1, 2024 – Nov 30, 2024 | Completed: Period of performance ended Nov 30, 2024 |
15B50525P00000012 CANCER DRUG BIOLOGICS (MCKESSON) OCT ORDER FY25 | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $21.5K | Oct 1, 2024 – Oct 31, 2024 | Completed: Period of performance ended Oct 31, 2024 |
15B50524P00000105 CANCER DRUG FOR NEW INMATE (SEPTEMBER ORDER) | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · Q517PHARMACY SERVICES | $21.5K | Sep 17, 2024 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with BIOLOGICS, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
